Details of the Drug Formulations

General Information of Drug (ID: DM0BQRS)

Drug Name
Spinosad Drug Info
Synonyms Natroba (TN)
Indication
Disease Entry ICD 11 Status REF
Head and body lice 1G00.0 Approved [1]
Pediculus capitis infestation 1G00.0 Approved [2]
Cross-matching ID
PubChem CID
24721309
CAS Number
168316-95-8
TTD ID
D09WCM
ACDINA ID
D00637

Full List of Drug Formulations Containing This Drug

Spinosad 140 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20355 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20356 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
Spinosad 1620 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20357 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20358 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
Spinosad 270 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20359 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20360 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
Spinosad 560 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20361 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20362 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
Spinosad 810 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20363 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20364 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------
Spinosad 90 mg tablet
Company Formulation ID FDA Description
Elanco Animal Health F20365 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Vicar Operating F20366 Magnesium stearate; Water; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose
------------------------------------------------------------------------------------

References

1 2011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4.
2 Spinosad FDA Label